YOU SEARCHED BY...
SEARCH BY...
Country
- Canada(2)
- India(1)
- Portugal(1)
- United Kingdom(3)
- United States(18)
Company Spotlight
Contract Service Directory
Activation Laboratories Ltd. (Actlabs)
Company Headquarters
41 Bittern Street
Ancaster, Ontario L9G 4V5
Canada
Contract Service Directory
- Accelerated Stability Studies
- Analytical Laboratory Services
- Analytical Methods Development
- Analytical Validation Studies
- Assay Development
- Bioanalytical Analysis LC/MS/MS
- Bioanalytical Services
- Bioavailability Studies
- Biological Testing
- Biomarker Research & Validation
- Cell Line Construction & Development
- Central Lab Services
- Chemical Analysis
- Chromatographic Analysis, LC/GC
- Chromatography
- CMC (Chemistry, Manfacturing & Controls)
- Container Testing
- Contaminant Analysis
- Contract Research
- Dissolution Testing
- Drug Development Services
- Environmental Analysis
- Forced Degradation Studies
- HPLC
- In Vitro Testing
- Lot Release Testing
- Mass Spectrometry
- Materials Analysis
- Methods Development
- Methods Validation
- Micro FT-IR Analysis
- Microbiological Testing
- Microscopic Analysis
- Mycoplasma Testing
- Particle Characterization
- Particle Size Analysis
- Pharmacokinetics
- Photostability
- Physical Testing
- Preclinical Testing
- Quality Control Testing
- R&D Services
- Raw Materials Analysis
- Stability Studies
- Stability, ICH
- Thermogravimetric Analysis
- Trace Metal Analysis, ICP
- UV-VIS Spectrophotometer Analysis
- Validation, Services
- Vitamin Analysis
- Water Testing: Chemical
- Water Testing: Microbiology
- Wet Chemical Analysis
- X-Ray Crystallography
- X-Ray Fluorescence
- X-Ray Powder Diffraction
Contract Services Directory
Related Content
-
Pharmaceutical Development for ADCs
Download the ADCs Poster.
-
Enhanced Delivery Options for Injectables
Download the Enhanced Delivery Options Poster.
-
BIOSIMILARS: Global Terminology, Strategy & Pathways
Download the Global Terminology, Strategy & Pathways Poster
-
Promotions & Moves
Akebia Therapeutics Names CMO
Jain to lead clinical development of the company’s HIF pipeline05.25.17
